Moderna Says New Data Support Need For COVID-19 Booster Shots

By Kelly Lienhard / September 16, 2021 at 3:09 PM
Moderna points to new clinical data showing those vaccinated with the company’s two-dose COVID-19 vaccine in the past year have had fewer breakthrough infections than those vaccinated more than a year ago, and says the data support its call for FDA to approve a booster shot of its vaccine. The company on Wednesday (Sept. 15) shared new analysis from its phase 3 COVE study that found 88 COVID-19 breakthrough cases occurred in the group of patients vaccinated with a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.